145 results about "Whole blood sample" patented technology

The invention provides a sample pretreatment automation method for flow cytometry, and belongs to the technical field of sample pretreatment for flow cytometry. A biological sample to be detected is collected and placed in a collection tube containing an EDTA-K2 anticoagulant for pretreatment; an automatic pipetting system is used for carrying out incubation reaction on an anticoagulant whole blood sample and an intelligent matching fluorescence labeling antibody mixed solution, and a double-layer game optimization verification system is used for verifying the rationality of an antibody adding proportion and reaction condition parameters; carrying out fluorescence characteristic readability index prediction on the incubated cell suspension by adopting an intelligent dilution parameter regulator model, dynamically adjusting hemolysis parameters and suspension conditions, and adding 1 * hemolysin working solution by using an automatic liquid adding device to carry out hemolysis treatment so as to finish pretreatment; the technical problems that in the pretreatment process of flow cytometry detection samples, parameters are often based on artificial experience, and the reproducibility and standardization degree of detection results are insufficient are solved.

The invention discloses a diluent for whole blood lateral immunochromatography detection as well as a preparation method and a detection method thereof, and belongs to the technical field of immunochromatography detection. The diluent solves the technical problems of unsmooth chromatography, background interference, poor stability of detection results and the like caused by red blood cells during direct detection of whole blood samples. The diluent comprises a buffer system, an osmotic pressure regulator glycine, a nonionic surfactant polysorbate, an erythrocyte aggregation inducer polyvinylpyrrolidone, a dynamic viscosity regulator trehalose, a blocking protein, a stabilizer combination L-methionine and L-histidine, and a composite formula of water. Red blood cells are effectively induced to gather and intercept on the sample pad through the synergistic effect of all the components, and meanwhile the stability of the chromatography process and the activity of the detection reagent are maintained. The diluent is mainly used for lateral immunochromatography quantitative detection of markers such as pro-enkephalin, C-reactive protein, cardiac troponin I or N-terminal pro-brain natriuretic peptide in a whole blood sample.

The invention provides a precise magnetic control whole blood rare cell flow magnetic separation system, a magnetic separation and identification method and application, and belongs to the technical field of micro-control flow biological detection. According to the invention, the magnetic separation chip can form a gradient magnetic field, and cells are fixed at a certain position on the sealing film under the combined action of magnetic field force and friction force, so that the separation of the cells is realized. Whole blood cell detection is carried out based on the gradient magnetic field, whole blood sample loading treatment can be directly carried out, the problem that the capture rate is reduced due to mechanical death, damage and stress gene expression caused by repeated elution / transfer steps is avoided, and the capture efficiency and cell activity of the chip are guaranteed; the magnetic field provided by electricity is not needed, the cost is low, the detection accuracy is high, the problems existing in existing CTC detection are solved, economic and practical values are achieved, further development of CTC detection can be promoted, and a novel and effective method is provided for complete blood cell separation detection.

The invention relates to the technical field of biomedical detection, and discloses a microfluidic biosensing identification method and system.The microfluidic biosensing identification method comprises the steps that a whole blood sample is obtained, measured and analyzed, a sample state vector is constructed, and working parameters of a sensor are dynamically adjusted; performing synchronous acquisition of multi-modal sensing signals to obtain the multi-modal sensing signals and environmental parameter signals; filtering compensation and correction are carried out on the environmental parameter signals; variational mode decomposition is carried out on the multi-mode net signal, physical constraint screening is carried out, and time domain and frequency domain characteristic parameters are extracted; carrying out evidence fusion and weighting on the multi-modal dynamic characteristic parameter set; carrying out transfer learning model training and time sequence correlation analysis to obtain a concentration estimation and diagnosis conclusion; according to the invention, direct detection of a whole blood sample, collaborative analysis of multi-modal signals, real-time monitoring of a dynamic process, adaptive compensation of an environment and accurate identification under a small sample condition can be realized.

The invention relates to the field of gene mutation detection, and particularly discloses a POCT (point-of-care testing) detection method for V617F mutation of a human JAK2 gene. According to the method, an integrated detection tube is divided into a cell lysis-nucleic acid binding magnetic bead area, a nucleic acid cleaning area and a nucleic acid elution-amplification area from top to bottom in sequence through a plurality of hydrophobic layers, the cell lysis-nucleic acid binding magnetic bead area is pre-filled with a lysis solution, the nucleic acid cleaning area is pre-filled with a nucleic acid cleaning solution, and the nucleic acid elution-amplification area is pre-filled with a nucleic acid elution solution. A nucleic acid elution-amplification system is pre-installed in the nucleic acid elution-amplification area, in the detection process, only a sample needs to be added into the cell lysis-nucleic acid binding magnetic bead area, a corresponding instrument is inserted, and operation is conducted, so that nucleic acid extraction, amplification and result reporting can be completed, and additional manual processing steps are not needed. The method has the advantages of simplicity and convenience in operation, short time consumption, high sensitivity, strong specificity, low pollution risk and the like, can be directly used for whole blood sample detection, meets the rapid diagnosis requirements of clinical outpatient service, and is particularly suitable for auxiliary diagnosis of BCR-ABL negative myeloproliferative tumors.

Described herein is a singleplex RT-LAMP-based tests using modified primer sets. Contrived whole blood samples containing HIV-1 or HCV virions were diluted in equal parts water and loaded directly into optimized RT-LAMP master mixes. To mitigate cold-chain storage dependence, RT-LAMP reactions were performed using a lyophilized master mix. The reactions were heated for, for example 30 minutes using a hand-held, battery-powered heating device for simultaneous virion lysis and amplification.

The application provides a full-passive microfluidic whole blood sample preparation device, which comprises, from bottom to top, a bottom support layer, a bottom hydrophilic layer, a bottom adhesive layer, a middle main body layer, a liquid outlet channel layer, an upper surface hydrophilic layer of the liquid outlet channel, a first intermediate adhesive layer, an upper layer main body layer, a second intermediate adhesive layer, a top cover layer and a product collection and storage cavity sealing patch which are laminated and assembled in sequence. The application does not need any external driving force or active surface treatment, and only relies on the material properties and ingenious structure design, so that the plasma / serum can be automatically and efficiently separated from trace whole blood, and the application has the advantages of simple structure, low cost, convenient operation, one-time use, instant detection application and the like.

The application discloses a combined filter for separating plasma from whole blood, comprising a whole blood sample adding chamber, a first combined filter membrane, an intermediate chamber, a second combined filter membrane and a plasma collecting chamber arranged in sequence along a filtering direction of a whole blood sample flow; and the whole blood sample is filtered multiple times through the first combined filter membrane and the second combined filter membrane to obtain a plasma sample. The application further provides a combined filter device and a method for separating plasma from whole blood. The combined filter provided by the application can further improve the recovery rate, recovery quality and recovery efficiency of the whole blood separation plasma, and meets the demand of in-vitro diagnosis on the pretreatment of the whole blood sample.

The invention relates to a method for detecting activation of specific T cells after tuberculosis infection and application of the method. Specifically, the invention provides a reagent combination for detection, and the reagent combination comprises an anti-CD4 antibody (CD4 antibody), an anti-CD154 antibody (CD154 antibody), an IFN-gamma detection antibody and a tuberculosis specific antigen. According to the method, through peripheral whole blood collection, PBMC cell separation, T cell activation (activation), activation termination (blocking), antibody labeling, membrane rupture, fixation, intracellular cytokine dyeing, flow cytometry detection and result analysis and judgment, the ratio of the expression IFN-gamma cells in the CD4 + CD154 + cells can be rapidly and accurately determined, and by combining an ROC curve and a constructed judgment standard, the content of the IFN-gamma cells in the CD4 + CD154 + cells can be determined, and the content of the IFN-gamma cells in the CD4 + CD154 + cells in the CD4 + CD154 + cells in the CD4 + CD154 + cells in the CD4 + CD154 + cells can be determined. And the sample to be detected is judged to be in a positive / negative / gray region, so that whether a patient is infected by the mycobacterium tuberculosis or not can be more accurately diagnosed, especially aiming at a whole blood sample from a special crowd.

FIELD: pharmacology.SUBSTANCE invention can be used to determine the concentration of an anti-tuberculosis drug in blood serum. The method for determining the concentration of bedaquiline in the blood serum in patients with tuberculosis or mycobacteriosis is that whole blood samples are centrifuged at 3000 rpm for 20 minutes, then the blood plasma is collected in sterile 1.5 mL Eppendorf tubes, then 900 mcL of acetonitrile are added to 300 mcL of plasma and centrifuged at 13500g for 15 minutes, then 1 mL of the supernatant is transferred to a chromatographic vial and make the assay by UHPLC MS / MS using an Athena UHPLC C18, 1.8 mcM, 120A, 2.1×100 mm chromatography column, when using an aqueous solution containing 5 g / L of ammonium acetate, 25 ml / L of concentrated acetic acid, 2 ml / L trifluoroacetic acid as mobile phase A and 100% acetonitrile as mobile phase B, the concentration of bedaquiline is determined using a pre-plotted calibration curve.EFFECT: determination of bedaquiline in human blood plasma in a time not exceeding 6 minutes.1 cl, 9 dwg, 6 tbl

The present application relates to the technical field of RNA extraction, and particularly relates to a pretreatment reagent, a method and a kit for RNA purification of whole blood samples. By introducing hydrophobic DESs as the core pretreatment component, the DESs are mixed with the whole blood sample in advance, the DESs form an independent phase layer after centrifugation by using the unique physicochemical properties, and the liposoluble drug components, inflammatory proteins and pigments are selectively extracted to the hydrophobic DESs phase and the RNA is preliminarily purified; the upper water phase of the pretreatment and purification is taken and added into a lysis solution containing a chaotropic salt to fully release the nucleic acid, and DNase I is introduced for digestion. The present application combines the pretreatment of hydrophobic DESs and the digestion of DNase I, and is used in combination with PVP (targeting adsorption of residual pigments and phenolic compounds), reduces the impurities of the lysis system through the front-end pretreatment, creates a low-interference and high-efficiency purification environment for the specific binding of RNA by the magnetic beads, and forms a synergistic removal network for the interference of complex samples.

The present disclosure provides methods and kits for determining antigen-specific T cell responses in a subject based on the use of a whole blood sample rather than isolated, enriched, and / or extracted peripheral blood mononuclear cells. The use of a whole blood sample to measure antigen-specific T cell responses in a subject streamlines the method by reducing sample preparation and consumption. These methods for determining antigen-specific T cell responses in a subject include contacting a whole blood sample from the subject with at least one antigen to form a mixture, contacting the whole blood sample with at least one staining reagent, and analyzing the mixture for antigen-specific T cells.

The invention provides a blood concentration prediction model based on artificial intelligence and a construction method and application thereof.A whole blood sample of a patient taking sirolimus is collected, the blood concentration is detected through liquid chromatography tandem mass spectrometry, CYP 3A4 / 5, CYP 2C8 and P-gp gene polymorphism is detected in combination with a high-resolution dissolution curve technology, and the blood concentration prediction model based on artificial intelligence is obtained. And constructing a database containing the multi-dimensional data. And training the database by using an extreme gradient lifting algorithm, establishing a high-precision sirolimus blood concentration artificial intelligence prediction model, and developing a mobile equipment end application to realize remote data acquisition and result display. The model is especially suitable for children with Carboxi-like vascular endothelioma, can dynamically monitor the blood concentration in real time, provides refined guidance for clinical treatment, reduces the treatment cost, and improves the treatment effect and safety.

This invention discloses direct amplification qPCR reagents, kits, and applications for whole blood samples. The amplification reagents include: a composite hot-start DNA polymerase system, a buffer system, a surfactant, an anti-contamination system, and an anti-inhibition enhancer system. The composite hot-start DNA polymerase system is obtained by mixing antibody-modified hot-start Taq enzyme and antibody-modified Taq1C2 mutant Taq enzyme in a predetermined ratio. The buffer system includes Tris-HCl, MgCl2, (NH4)2SO4, and KCl. The surfactants include Tween-20 and NP-40. The anti-contamination system includes UDG enzyme and dNTPs, wherein the dNTPs are composed of dATP, dGTP, dCTP, dTTP, and dUTP. The anti-inhibition enhancer system includes D-trehalose, L-carnitine, DMSO, BSA, and SSB single-chain binding protein.

A coagulation test device for measuring clot time and clot characteristics of whole blood samples under different hemostatic conditions. The test results are used as an aid in the management of patients with unexplained coagulopathy for the purpose of helping the physician to determine appropriate clinical measures to hemostasis in the patient.

The invention relates to the technical field of image processing, and further relates to a tumor characteristic spectrum construction method based on CTC enrichment and multi-omics analysis. The method comprises the following steps: 1, sequentially carrying out spiral inertial focusing and deterministic lateral displacement sorting on a whole blood sample to be detected, and finishing single-cell microcavity positioning capture of circulating tumor cells in a single-cell microcavity capture array region; 2, acquiring a time-varying curve of an oxygen molecule concentration value for each positioned and captured circulating tumor cell, and acquiring a metabolic function characteristic parameter group; 3, forming a multi-omics joint feature vector in combination with the metabolic function feature parameter group; and 4, constructing a circulating tumor cell subset based on the multi-omics combined feature vector, extracting symbolic molecular features, and integrating and outputting a tumor feature spectrum. According to the invention, more stable technical support can be provided for tumor heterogeneity analysis, metastasis potential evaluation and curative effect monitoring.

A blood gas analyzer (1) for measuring an analyte parameter in a blood sample, such as a whole blood sample, aspirated from a handheld blood sample container (100) into the blood gas analyzer (1) comprises a controller (8) and a sensor system (5) for detecting the presence, position and / or orientation of the handheld blood sample container (100) relative to an inlet structure (12a / b). An aspiration system is provided for aspirating the blood sample from the handheld blood sample container (100), which aspiration system can be connected to the handheld blood sample container (100). A user interface system is provided for outputting instructions to a user (102) of the blood gas analyzer (1), the instructions being selected from a set of pre-stored instructions. The controller (8) selects one of the at least two sets of pre-stored instructions based on an evaluation of signals obtained from the sensor system.

The present invention relates to a method and apparatus for determining the activity of clotting factors in diluted capillary whole blood, citrated whole blood and citrated plasma. The invention also includes the detection of hemoglobin content in the whole blood sample to correct for clotting time so that the clotting time values are not affected by hemoglobin and hematocrit.

The application discloses a kind of based on DNA methylation's construction method of biological age prediction model, the application is downloaded from GEO data website, derived from Chinese population, contains calendar age data, whole blood sample 450k methylation chip data, by the method of elastic network combined bootstrap, 31 methylation sites of modeling candidate are screened, multiple linear regression, support vector machine, random forest and gradient boosting regression tree are used to carry out preliminary construction and evaluation of model, then further filter methylation sites using full subset regression, obtain methylation age prediction model based on 18 methylation sites.Finally, using any provincial team natural population data, methylation age prediction model is optimized, and finally the biological age prediction model based on 18 methylation sites is obtained.The model is suitable for Chinese population, the number of methylation sites contained is less, is not affected by blood cell components, and the prediction accuracy is good.

The invention discloses a reagent and a method for improving the tolerance of a PCR inhibitor and application, and belongs to the technical field of molecular biology. According to the invention, the thermosensitive uracil DNA glycosidase and the deoxyuridine triphosphate are combined and used as the PCR antiinhibitor to be applied to DNA amplification of a whole blood sample, and experiments prove that the composition can improve the endurance capacity of a PCR reaction system to a whole blood inhibitor, reduce the false negative rate and improve the accuracy and reliability of detection. Meanwhile, the method for carrying out PCR reaction by using the composition is simple to operate, low in cost and high in nucleic acid detection sensitivity. Therefore, the reagent and the method have a good application prospect in detection of nucleic acid extracted from a whole blood sample.

The invention provides a cell product production instrument and a cell product production method using the same. The cell product production instrument comprises a whole blood sample bag; a magnetic separation device; the target cell processing module comprises a module main body, an accommodating cavity is formed in the module main body, a filter membrane is arranged in the accommodating cavity, the accommodating cavity is divided into a first space and a second space by the filter membrane, and a transfection reaction cavity capable of accommodating target cells is formed in the bottom of the first space; a heating module; a sample pumping assembly; the cleaning fluid pumping assembly is used for pumping the cleaning fluid in the cleaning fluid bag into the first space through the cleaning fluid inlet; the reagent pumping assembly is used for pumping a transfection reagent and / or a culture medium into the first space through the reagent inlet; and the cell product pumping assembly is used for conveying the transfected target cells in the first space into the finished blood bag through the cell product outlet. According to the invention, manual intervention and process breakpoints are thoroughly eliminated by realizing full-automatic internal circulation among the modules.

The application relates to a biochemical analyzer and a detection method for detecting glycated hemoglobin. The hemoglobin concentration and the glycated hemoglobin concentration of a to-be-detected whole blood sample are obtained, and the content proportion of the glycated hemoglobin is calculated according to the hemoglobin concentration and the glycated hemoglobin concentration. The hemoglobin concentration is obtained by the following steps: obtaining a first absorbance of a to-be-detected sample liquid at a hemoglobin measurement wavelength, wherein the to-be-detected sample liquid is prepared by mixing a to-be-detected whole blood sample, a hemolytic agent and a hemoglobin detection reagent; obtaining at least two second absorbances of the to-be-detected sample liquid at at least two different correction wavelengths, wherein the correction wavelengths are designed so that the absorbance of a lipid interferent at the correction wavelength is greater than the absorbance of hemoglobin at the correction wavelength; correcting the first absorbance according to the second absorbance; and determining the hemoglobin concentration according to the corrected first absorbance. The application can improve the accuracy of hemoglobin detection.

The utility model relates to the technical field of medical instruments, in particular to a separable aluminum foil plate-shaped dried blood spot whole blood sample storing and packaging system which comprises dried blood spot storing filter paper and an aluminum foil base plate. The dried blood spot preservation filter paper comprises filter paper and paper, the lower edge of the filter paper and the upper edge of the paper are overlapped and fixedly connected, a plurality of first cutting lines are arranged on the filter paper, and a plurality of dried blood spot collecting points are defined by the first cutting lines on the filter paper; a plurality of second cutting lines are arranged on the aluminum foil substrate and divide the aluminum foil substrate into a plurality of aluminum foil substrate units; each aluminum foil substrate unit comprises a substrate unit main body, a plurality of bubble caps, a drying agent and aluminum foil; due to the design of the aluminum foil substrate unit, the external environment can be effectively isolated, the storage life of a sample is prolonged, meanwhile, a dried blood spot collecting point can be easily separated and taken out through a cutting line, the operation is simple, and the sample treatment efficiency is greatly improved.

The present application relates to the technical field of analytical detection, and particularly relates to a detection method for simultaneously detecting folic acid and 5-methyltetrahydrofolic acid in human whole blood. The sample to be detected is mixed with Vc, saturated zinc sulfate solution, and a mixed solution of methanol, acetonitrile and isopropyl alcohol, and then centrifugal separation supernatant is carried out for liquid chromatography detection. The present application provides a detection method with low cost, simple steps, and good separation of unmetabolized folic acid and its metabolite 5-methyltetrahydrofolic acid in whole blood samples. The method can meet the requirements of precision, accuracy and matrix effect in the verification process. Moreover, the detection method of the present application can achieve accurate detection effect without introducing internal standard. The method plays an important role in evaluating the content of folic acid and its metabolites in whole blood samples.

This invention relates to the field of drug concentration detection technology, specifically to a rapid method for detecting blood drug concentrations in emergency patients. The method involves collecting time-series biochemical reaction signals from whole blood samples within a fixed time window, obtaining a net signal sequence after benchmark removal; constructing a baseline linear reference sequence connecting the zero point and the endpoint using a preset cutoff time endpoint value; calculating the vertical difference between the net signal and this reference to determine the time of maximum deviation; and finally, using the endpoint value and the time of maximum deviation as a two-dimensional index to query a preset compensation table and output the drug concentration corrected for hematocrit. This method utilizes reaction kinetic morphology characteristics to decouple the diffusion hindrance effect caused by high hematocrit, avoiding false low concentration results due to incomplete reaction equilibrium. It significantly improves the accuracy and reliability of blood drug concentration detection in emergency settings under conditions of no centrifugation and direct whole blood measurement.

The invention discloses a compound enzyme solution for improving total cholesterol test current, which is prepared from the following components in percentage by weight: 20 to 200mM of buffer solution, 0.5 to 200mg / mL of cholesterol oxidase, 0.1 to 100mg / mL of cholesterol esterase, 0.1 to 25mg / mL of peroxidase, 1 to 6 percent of potassium ferricyanide, 0.1 to 8 percent of glucoside and the balance of water. And the cellulose accounts for 0.01%-2%. When a whole blood sample is tested, the compound enzyme liquid of lipoprotein can be quickly decomposed, so that the test current is improved, and the test time is shortened.

The invention relates to the technical field of biomedical engineering, and discloses a detection method for esophageal squamous carcinoma CTC enrichment and immunotherapy curative effect dynamic evaluation, and the method utilizes a micro-fluidic chip to carry out electrical impedance detection and physical preliminary screening on cells in a whole blood sample. And performing anti-reclosing time sequence verification on the screened interstitial circulating tumor cells, triggering transient flow resistance regulation and control when conditions are met, and opening a lateral shunt channel to reduce the flow velocity of a main flow channel. And meanwhile, the adaptive optical imaging unit is synchronously switched to a long integral time mode to collect a fluorescence image. And finally, the data calculation terminal calculates an immunotherapy curative effect evaluation index in combination with cell counting, an omission compensation item and PD-L1 expression intensity. Through synchronous linkage of the flow velocity and exposure, the problem of weak fluorescence signal detection under high-speed flow is solved, and the evaluation accuracy is improved.

Absorbance is used to measure hemoglobin and bilirubin parameters in whole blood samples.SOLUTION: System 10 includes an optical-sample module 20, a spectrometer module 100, a fiber-optic assembly 90 that optically connects optical-sample module 20 to spectrometer module 100, and a processor module 150. The optical-sample module 20 includes a light-emitting module having an LED light source, a cuvette assembly, and a calibration-light module. Processor module 150 receives and processes electrical signals from spectrometer module 100 and converts the electrical signals into output signals usable to display and report hemoglobin parameter values and / or total bilirubin parameter values for a whole blood sample.SELECTED DRAWING: Figure 1

The embodiment of the utility model discloses a whole blood detection device integrated with a self-negative-pressure and surface-modified flow aiding structure, relates to the technical field of biological detection, and can effectively improve the detection efficiency of a whole blood sample. The device comprises a plate piece, a sealing piece and a filtering piece, the plate is provided with a containing cavity, one side of the plate is further provided with a sample adding opening, the sample adding opening is communicated with the containing cavity, a detection agent is arranged in the containing cavity, and a flow assisting structure is further arranged in the containing cavity and used for guiding flow of an object to be detected; the sealing piece plugs the sample adding opening; the filtering piece is arranged in a space defined by the sealing piece and the plate piece, a collecting cavity is formed between the filtering piece and the sealing piece, and the air pressure in the collecting cavity is lower than the atmospheric pressure. The method is suitable for the scene of rapid blood detection.

The present invention provides a rapid method using whole blood samples for determining the severity of COVID-19 disease arising from SARS-CoV-2 infection and monitoring progression and treatment of t